IL10 and COVID-19: It is suggested that the exacerbated IL-10 production might work as an immune activating agent by for example stimulating the production of other factors of the cytokine storm, thereby amplifying the viral sepsis-related hyperinflammation in critically ill COVID-19 patients (252, 253).